Bradford S Hoppe

Summary

Publications

  1. doi request reprint Improving the therapeutic ratio by using proton therapy in patients with stage I or II seminoma
    Bradford S Hoppe
    Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL, USA
    Am J Clin Oncol 36:31-7. 2013
  2. doi request reprint Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma
    Bradford S Hoppe
    Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL 32206, USA
    Int J Radiat Oncol Biol Phys 84:449-55. 2012
  3. doi request reprint Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results
    Bradford S Hoppe
    Department of Radiation Oncology, College of Medicine, University of Florida, Jacksonville, FL, USA
    Clin Lung Cancer 13:352-8. 2012
  4. pmc Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, FL, USA
    Cancer 118:4619-26. 2012
  5. ncbi request reprint Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA
    Oncology (Williston Park) 26:456-9, 462-5. 2012
  6. doi request reprint Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, FL, USA
    Int J Radiat Oncol Biol Phys 83:260-7. 2012
  7. ncbi request reprint Proton therapy for prostate cancer
    Bradford Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA
    Oncology (Williston Park) 25:644-50, 652. 2011
  8. doi request reprint Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, USA
    Radiother Oncol 97:425-30. 2010
  9. doi request reprint Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer
    Nancy P Mendenhall
    University of Florida Proton Therapy Institute, Jacksonville, FL 32206, USA
    Int J Radiat Oncol Biol Phys 82:213-21. 2012
  10. doi request reprint Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 72:763-9. 2008

Collaborators

Detail Information

Publications25

  1. doi request reprint Improving the therapeutic ratio by using proton therapy in patients with stage I or II seminoma
    Bradford S Hoppe
    Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL, USA
    Am J Clin Oncol 36:31-7. 2013
    ....
  2. doi request reprint Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma
    Bradford S Hoppe
    Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL 32206, USA
    Int J Radiat Oncol Biol Phys 84:449-55. 2012
    ..We investigated the dosimetric impact of proton therapy (PT) on various cardiac subunits in patients with Hodgkin lymphoma (HL)...
  3. doi request reprint Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results
    Bradford S Hoppe
    Department of Radiation Oncology, College of Medicine, University of Florida, Jacksonville, FL, USA
    Clin Lung Cancer 13:352-8. 2012
    ..Early outcomes are presented here for patients who received proton therapy with concurrent chemotherapy for non-small-cell lung cancer (NSCLC)...
  4. pmc Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, FL, USA
    Cancer 118:4619-26. 2012
    ..This study sought to evaluate patient-reported health-related quality of life following proton therapy for prostate cancer in men ≤ 60 years old...
  5. ncbi request reprint Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA
    Oncology (Williston Park) 26:456-9, 462-5. 2012
    ..This review addresses the rationale and evidence for--and the challenges, cost implications, and future development of--PT as an important part of the treatment strategy in HL...
  6. doi request reprint Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, FL, USA
    Int J Radiat Oncol Biol Phys 83:260-7. 2012
    ....
  7. ncbi request reprint Proton therapy for prostate cancer
    Bradford Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA
    Oncology (Williston Park) 25:644-50, 652. 2011
    ..Early results from these studies are promising and will likely help make proton therapy for the treatment of prostate cancer more cost-effective...
  8. doi request reprint Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy
    Bradford S Hoppe
    University of Florida Proton Therapy Institute, Jacksonville, USA
    Radiother Oncol 97:425-30. 2010
    ..In this study, we compare xSBRT treatment plans with proton-based SBRT (pSBRT) to determine whether dose to normal structures could be reduced if SBRT was delivered with protons...
  9. doi request reprint Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer
    Nancy P Mendenhall
    University of Florida Proton Therapy Institute, Jacksonville, FL 32206, USA
    Int J Radiat Oncol Biol Phys 82:213-21. 2012
    ..To report early outcomes with image-guided proton therapy for prostate cancer...
  10. doi request reprint Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 72:763-9. 2008
    ..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy...
  11. doi request reprint Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study
    R Charles Nichols
    University of Florida Proton Therapy Institute, University of Florida College of Medicine, Jacksonville, USA
    Clin Lung Cancer 12:252-7. 2011
    ..The purpose of this study was to determine the potential benefit of proton radiation therapy over photon radiation therapy in patients with unresectable stage III non-small-cell lung cancer...
  12. doi request reprint Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression
    R Charles Nichols
    Department of Radiation Oncology, University of Florida, Gainesville, FL, USA
    Int J Radiat Oncol Biol Phys 82:1222-6. 2012
    ..The present study was undertaken to determine whether this would also be the case with conformal protons...
  13. pmc Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials
    Randal H Henderson
    University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA edu
    Acta Oncol 52:463-9. 2013
    ....
  14. doi request reprint Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10021, USA
    Head Neck 30:925-32. 2008
    ....
  15. doi request reprint Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer
    Rovel J Colaco
    University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA
    Acta Oncol 52:506-13. 2013
    ..We present outcomes for the first known series of limited-stage SCLC patients treated with proton therapy and a dosimetric comparison of lung and esophageal doses with intensity-modulated radiation therapy (IMRT)...
  16. doi request reprint Hip fractures and pain following proton therapy for management of prostate cancer
    Raul Valery
    University of Florida Proton Therapy Institute, University of Florida College of Medicine, Jacksonville, Florida 32206, USA
    Acta Oncol 52:486-91. 2013
    ..Proton therapy (PT) for prostate cancer reduces rectal and bladder dose, but increases dose to the femoral necks. We assessed the risk of hip fracture and pain in men treated with PT for prostate cancer...
  17. ncbi request reprint Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:1365-72. 2008
    ..To analyze the recent experience of patients with adenoid cystic carcinoma treated with radiation therapy at Memorial Sloan-Kettering Cancer Center...
  18. pmc Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
    Whoon Jong Kil
    Department of Radiation Oncology, University of Florida, Gainesville, Florida, USA
    Acta Oncol 52:492-7. 2013
    ..To investigate post-treatment changes in serum testosterone in low- and intermediate-risk prostate cancer patients treated with hypofractionated passively scattered proton radiotherapy...
  19. doi request reprint Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer
    Lisa McGee
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida 32206, USA
    Acta Oncol 52:470-6. 2013
    ..0142). Conclusion. Definitive management of men with large prostates without ADT was associated with low rates of genitourinary and gastrointestinal toxicity...
  20. doi request reprint Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 72:1283-6. 2008
    ..We examined the rate of acute skin toxicity within a prospectively managed database of patients treated for early-stage non-small-cell lung cancer (NSCLC) and investigated factors that might predict skin toxicity...
  21. doi request reprint Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy
    Kristy Smith
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL 32610 0385, USA
    Int J Radiat Oncol Biol Phys 82:1122-7. 2012
    ..in patients receiving Bexxar alone for nonbulky disease...
  22. doi request reprint Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10165, USA
    J Clin Oncol 26:1858-64. 2008
    ..To analyze outcome, prognostic factors, and toxicities in patients with diffuse large-cell lymphoma (DLCL) who received involved-field radiotherapy (IFRT) before high-dose chemotherapy with autologous stem-cell rescue (ASCR)...
  23. doi request reprint Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer
    Romaine C Nichols
    University of Florida Proton Therapy Institute, Jacksonsville, FL, USA
    Int J Radiat Oncol Biol Phys 83:158-63. 2012
    ..To determine the potential role for adjuvant proton-based radiotherapy (PT) for resected pancreatic head cancer...
  24. doi request reprint Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity
    R Charles Nichols
    University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA
    Acta Oncol 52:498-505. 2013
    ..To review treatment toxicity for patients with pancreatic and ampullary cancer treated with proton therapy at our institution...
  25. ncbi request reprint Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:691-702. 2007
    ..To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center...